Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump’s broad tax and spending law.This article was originally […]
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.This article was originally published on MedicalXpress.com
The COVID-19 pandemic not only disrupted children’s education, recreation, and social lives, but it also increased the prevalence of obesity in the U.S. pediatric population by roughly 1 million youngsters, according to a study led […]
The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become household names.This […]
A Curtin University-led study has found that where Australians live has a measurable influence on their body weight, with local food environments and neighborhood design playing a big part in shaping health outcomes.This article was […]
Researchers have conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, according to a […]
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.This article was originally published on MedicalXpress.com
Changing the amount of sweetness in a person’s diet has no impact on their liking for sweet foods, the results of a new trial suggest. The results also showed no difference in indicators of cardiovascular […]
A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over one billion people worldwide, the World Health Organization said Monday.This article was originally published […]
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide patients. People with obesity who lost […]
© 2025 SimplyWell.ca